Solara Active Pharma Reports Mixed Q4 Results with Revenue Growth and Profitability Variations
50 minutes agoBusiness
32LENS
4 SourcesKerala, India
TBNthebalanced.news

Solara Active Pharma Reports Mixed Q4 Results with Revenue Growth and Profitability Variations

Solara Active Pharma Sciences reported mixed financial results for Q4 FY26, with consolidated net profit of Rs 9.60 crore according to some sources, while others reported a net loss of Rs 17.43 crore. Revenue from operations increased between 27.8% and 41.9% year-on-year, reaching around Rs 349-387 crore. Operating costs and expenses rose, impacting margins. For the full year FY26, the company posted a consolidated net loss of Rs 7.41 crore, despite a 6.6% rise in revenue to Rs 1,368.98 crore.

Political Bias
0%100%0%
Sentiment
58%
AI analysis of 4 sources · Published under editorial oversight by The Balanced News
Analysed 15 May 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Political bias across 4 sources
● Left 0%● Center 100%● Right 0%

The article group primarily presents corporate financial data without political framing. Coverage focuses on company performance metrics, with no evident political perspectives or partisan interpretations. Sources emphasize financial outcomes and operational details, maintaining a business-centric viewpoint without political commentary.

Sentiment — Neutral (58/100)

The overall sentiment is mixed, reflecting contrasting reports of profit and loss alongside revenue growth. While some sources highlight positive aspects like increased sales and profitability, others emphasize losses and margin pressures. The tone remains factual and neutral, balancing optimistic and cautious elements in the company's financial performance.

How 4 sources covered this story

Each source's own headline, political lean, and sentiment — so you can see framing differences at a glance.

SourceTheir headlineBiasSentiment
moneycontrolSOLARA ACTIVE P Standalone March 2026 Net Sales at Rs 387.29 crore, up 41.86 Y-o-Y- Moneycontrol.comCenterPositive
businessstandardSolara Active Pharma spurts after reporting turnaround Q4 perfromanceCenterPositive
businessstandardSolara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarterCenterNeutral
freepressjournalSolara Active Pharma Q4 Loss Widens To 17 Crore Despite Revenue GrowthCenterNegative

Coverage timeline

freepressjournal broke this story on 15 May, 08:27 am. Other outlets followed.

  1. 1
    freepressjournal15 May, 08:27 am
    Solara Active Pharma Q4 Loss Widens To 17 Crore Despite Revenue Growth
  2. 2
    businessstandard15 May, 09:40 am
    Solara Active Pharma Sciences reports consolidated net profit of Rs 9.60 crore in the March 2026 quarter
  3. 3
    businessstandard15 May, 09:40 am
    Solara Active Pharma spurts after reporting turnaround Q4 perfromance
  4. 4
    moneycontrol15 May, 10:22 am
    SOLARA ACTIVE P Standalone March 2026 Net Sales at Rs 387.29 crore, up 41.86 Y-o-Y- Moneycontrol.com

Lens Score breakdown

32/100
Public interest0/100
Coverage gap90%

Well-covered story — coverage matches public importance.

Who's involved

Institutions and figures named across source coverage.

Corporate
Brahmaputra InfraRetaggio IndustriesSolara Active Pharma Sciences LtdChalet HotelsThangamayil JewellerySolara Active Pharma Sciences

Story context

Category
Business
Location
Kerala, India
Sources analysed
4
Last analysed
15 May 2026
Key entities
CroreIndian rupeeNet incomeRevenueJewelleryEarnings before interest, taxes, depreciation, and amortizationIbuprofenHindustan Aeronautics LimitedBSE SENSEXAdani GroupHeat waveBalance of trade